1999
DOI: 10.1111/j.1542-474x.1999.tb00372.x
|View full text |Cite
|
Sign up to set email alerts
|

Right Ventricular Dysplasia: A Report of 24 Adult Cases

Abstract: Right ventricular dysplasia is characterized by an abnormality in the development of part of the right ventricular musculature. Patients with right ventricular dysplasia may present 4 t h ventricular tachycardia, supraventricular arrhythmias, rightheart failure or asymptomatic cardiomegdy. Twenty-two adult patients with right ventricular dysplasia who had recurrent ventricular tachycardia were seen during a 7-year period. The male/female ratio was 2.7: 1. The mean age at the time of hospitalization n u 3 9 yea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

9
436
1
15

Year Published

2000
2000
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 310 publications
(461 citation statements)
references
References 29 publications
(1 reference statement)
9
436
1
15
Order By: Relevance
“…ARVC/D is familial in up to 50% of cases. 1,[8][9][10][11][12] Since the identification of mutations in the genes encoding the desmosomal proteins desmoplakin (DSP) 13 and plakophilin-2 (PKP2), [14][15][16][17] followed by mutations in desmocollin-2 (DSC2), 18 desmoglein-2 (DSG2) 19 and plakoglobin (JUP), 20 it has been recognised that ARVC/D is mainly a disorder of the cardiac desmosome (figure 2), a cell adhesion complex residing in the intercalated disk of cardiomyocytes. Comprehensive screening of these genes encoding the proteins of this complex leads to the identification of a pathogenic mutation in approximately 40 to 60% of ARVC/D patients.…”
Section: Netherlands Heart Journal Volume 18 Number 12 December 2010mentioning
confidence: 99%
See 1 more Smart Citation
“…ARVC/D is familial in up to 50% of cases. 1,[8][9][10][11][12] Since the identification of mutations in the genes encoding the desmosomal proteins desmoplakin (DSP) 13 and plakophilin-2 (PKP2), [14][15][16][17] followed by mutations in desmocollin-2 (DSC2), 18 desmoglein-2 (DSG2) 19 and plakoglobin (JUP), 20 it has been recognised that ARVC/D is mainly a disorder of the cardiac desmosome (figure 2), a cell adhesion complex residing in the intercalated disk of cardiomyocytes. Comprehensive screening of these genes encoding the proteins of this complex leads to the identification of a pathogenic mutation in approximately 40 to 60% of ARVC/D patients.…”
Section: Netherlands Heart Journal Volume 18 Number 12 December 2010mentioning
confidence: 99%
“…1,2 The clinical presentation of ARVC/D is highly variable, ranging from asymptomatic to sudden cardiac death (SCD) and/or heart failure, even at a relatively young age. 3,4 The clinical diagnosis of ARVC/D is based upon criteria originally proposed by an international Task Force in 1994; 5 these have recently been modified to improve diagnostic sensitivity and maintain diagnostic specificity.…”
Section: Netherlands Heart Journal Volume 18 Number 12 December 2010mentioning
confidence: 99%
“…The gross pathognomonic features of AC consist of RV aneurysms, whether single or multiple, located in the so-called "triangle of dysplasia" (i.e. inflow, apex and outflow tract) [2,14]. Nevertheless, grossly normal hearts have been reported in whom only a careful histopathology investigation can reveal AC features.…”
Section: Pathological Findingsmentioning
confidence: 99%
“…This leads to increased motion-related artifacts from ghosting of fat from the chest wall if the patient is unable to maintain a breathhold or possibly more significant aliasing artifacts from fat within the shoulder when fields-of-view (FOVs) are small. Furthermore, bright signal from pericardial fat may obscure proper identification of enhancing myocardial scar, which may be particularly problematic in regions of thinned myocardium such as in chronic infarction or in the right ventricle (6,7). We propose a technique that allows effective fat suppression with minimal impact on the normal IR-GRE acquisition: that is, a method that does not alter the normal delayed enhancement protocols or change the TI times used in a nonfat suppressed delayed enhancement study.…”
mentioning
confidence: 99%